COVID-19 thyroid disorders: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) (Created page with "__NOTOC__ {{COVID-19 thyroid disorders}} {{CMG}} {{AE}}") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
==Overview== | |||
==Historical Perspective== | |||
==Classification== | |||
==Pathophysiology== | |||
==Causes== | |||
==Differentiating ((Page name)) from other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, and Prognosis== | |||
==Diagnosis== | |||
===Diagnostic Study of Choice=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Electrocardiogram=== | |||
===X-ray=== | |||
===Echocardiography or Ultrasound=== | |||
===CT scan=== | |||
===MRI=== | |||
===Other Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | |||
===Medical Therapy=== | |||
===Surgery=== | |||
===Primary Prevention=== | |||
===Secondary Prevention=== | |||
==References== | |||
Revision as of 15:53, 17 May 2022
Template:COVID-19 thyroid disorders
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: